Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $6.4500 (-1.53%) ($6.4500 - $6.4500) on Sat. Aug. 14, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.85% (three month average) | RSI | 53 | Latest Price | $6.4500(-1.53%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.1% a day on average for past five trading days. | Weekly Trend | CGEN declines -0.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting CGEN price | CGEN will decline at least -1.925% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.925% (StdDev 3.85%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $0.76(-88.22%) | Resistance Level | $6.72 | 5 Day Moving Average | $6.59(-2.12%) | 10 Day Moving Average | $6.68(-3.44%) | 20 Day Moving Average | $6.72(-4.02%) | To recent high | -26.7% | To recent low | 1% | Market Cap | $N/A | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |